Focus: Hidden - New Jersey

• share
• favorite_border

Those first holidays with college freshmen returning home can be exciting . . . and frustrating. Here's how to cope.

• share
• favorite_border

ISPOR recognized recipients at its 19th Annual European Congress. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR).

• share
• favorite_border

ISPOR held an issue panel entitled, "Using Observational (Real-World) Data in Health Technology Assessment: Route to Confusion or Better Decisions?" The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted its third plenary session, "How to Control Costs and Improve Access to Medicines: Lessons from the InterQuality Project," at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

ISPOR held an issue panel entitled, "Should Health Technology Assessment Guidelines Recommend Inclusion of Future Medical Costs?," at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

ISPOR hosted an issue panel entitled, "Real World Evidence to Support Value Proposition and Reimbursement at Launch: The Aspirational Meets the Impractical?,'" at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

Article roundups several PPPL news releases from the 58th annual APS Division of Plasma Physics conference.

• share
• favorite_border

ISPOR offered an issue panel, "Valuing Transformative Medicines in Rare Diseases: Methods and Madness," at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

ISPOR held an issue panel this afternoon entitled, Emerging US Value Frameworks: Are There Lessons From – Or For – Europe? The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a session this afternoon entitled, "Adaptive Pathways and Patient Access: Pushing Payer Boundaries or Facilitating New Payment Models?" at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session, "Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability," this morning at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning on Incentivizing Research Into the Effectiveness of Medical Devices at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning entitled, "The Potential and Pitfalls of Using Multi-Criteria Decision Analysis to Support Health Technology Assessment." The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

Physicist Egemen Kolemen is sharing a grant from ExxonMobil to research whether plasma could reduce greenhouse gas emissions associated with oil wells.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) led a session this afternoon entitled, "From Testimonials to Qualitative Research Embedded in Clinical Trials: How Do Health Technology Assessment Bodies Consider the Voice of Rare Disease Patients When Granting Access to Orphan Drugs?" The discussion took place at the Society’s 19th Annual European Congress—in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this afternoon on "New Approaches to Survival Modeling in Oncology" at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in Vienna, Austria.

• share
• favorite_border

Two Rutgers graduate school alumni will be forever connected. A living donor transplant kept one man alive and left another glad he was able to help his friend and save his life by donating part of his liver.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 19th Annual European Congress in Vienna, Austria this morning with the first plenary session, "What Synergies Could Be Created Between Regulatory and Health Technology Assessments?"

• share
• favorite_border

Piece describes R. Goldstone's 2015 Nuclear Fusion Award.

• share
• favorite_border

A proposal from PPPL scientists has been chosen as part of a national initiative to develop the next generation of supercomputers. Known as the Exascale Computing Project, the initiative will include a focus on exascale-related software, applications, and workforce training.

• share
• favorite_border

For many years, doctors, scientists and researchers have urged that clinical drug trial data be shared to accelerate medical advances in treating multiple diseases. But two years after free patient data became available in a major data-sharing project, the biggest surprise is how little it is being used.

• share
• favorite_border

Burning coal for electricity is in decline, while the use of natural gas, solar and wind power are on the rise. But how close are we to creating a clean energy economy to help protect our planet from the impacts of climate change? Rutgers Today asked Paul G. Falkowski, Bennett Smith Professor in Business and Natural Resources in the Department of Earth and Planetary Sciences and director of the Rutgers Energy Institute, about energy use, the presidential candidates’ positions and the outlook for cleaner energy.

• share
• favorite_border

The Alzheimer’s Drug Discovery Foundation (ADDF) announced today the relaunch of CognitiveVitality.org, its brain health and dementia prevention website. The streamlined, easy-to-navigate site separates fact from fiction and empowers people to make smarter choices for their brain health.

• share
• favorite_border

A team of scientists at the U.S. Department of Energy’s (DOE) Princeton Plasma Physics Laboratory (PPPL) has won the 2016 Edison Patent Award for inventing an on-demand method to create a badly needed isotope used routinely in medical imaging devices to diagnose diseases such as cancer and heart disease.

• share
• favorite_border

Wrap-up of PPPL and collaborator presentations at 26th IAEA conference in Japan.

• share
• favorite_border

A Rutgers Cancer Institute of New Jersey researcher has received a $596,250 award (W81XWH-16-1-0358) from the U.S. Department of Defense to study the role of chronic stress in breast cancer development. The focus of the work is to explore how chronic stress impacts breast cancer risk and to provide a foundation that can guide prevention strategies.

• share
• favorite_border

The Nineteenth Annual Meridian Health Affiliated Foundations’ Gala, Innovation Has No Boundaries, will be held on Saturday, November 19 from 6:00 p.m. to 11:00 p.m. at the Ocean Place Resort & Spa in Long Branch. This signature fundraising event benefits Hackensack Meridian Health’s not-for-profit hospitals and community health programs in Monmouth, Ocean and Middlesex counties.

• share
• favorite_border

This century, our world will be flooded with hundreds of billions of smartphones, gadgets, sensors and other smart objects connected to the internet. At Rutgers University, Dipankar “Ray” Raychaudhuri is at the forefront of efforts to redesign the internet to handle the enormous increase in traffic.

• share
• favorite_border

Notable alumni from across the globe return to Rutgers University for a special day of interaction with students on the occasion of its 250th birthday

• share
• favorite_border

Jean and Ric Edelman today pledged $25 million to preserve and expand the Rowan University Fossil Park in Mantua Township, N.J.

• share
• favorite_border

ECS is celebrating Open Access Week this year by giving the world a preview of what complete open access will look like. From October 24th through October 30th, we are taking down the paywall to the ECS Digital Library, making over 132,000 scientific articles free and accessible to anyone.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of the scientific sessions for its 19th Annual European Congress that will begin next week, 29 October-2 November 2016 in Vienna, Austria.

• share
• favorite_border

Rutgers is receiving a $4 million NSF grant to create and assess a regional computing infrastructure for collaborative data-intensive science. The team includes faculty at the Rutgers Discovery Informatics Institute, Penn State University, City University of New York, Drexel and Temple.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the three winners and six finalists of the 2016 Blavatnik Regional Awards. The winners include an ecologist who has advanced our understanding of how forest ecosystems recover or die during drought; a physical chemist who studies electron transport in solar energy capture and conversion; and a condensed matter physicist who has provided theoretical guidance to experiments that have led to the direct observation of Majorana fermions. The six finalists perform pioneering research in diverse areas including astrophysics, engineering, biochemistry and structural biology, molecular and cellular biology, theoretical chemistry, and biomedical engineering.

• share
• favorite_border

Most patients who need blood transfusions – including those who are critically ill – can be given blood when their hemoglobin drops to a lower level than practiced traditionally, according to AABB, a national association of blood banks that based its recommendation on research led by Rutgers University.

• share
• favorite_border

About 100 million years ago, a lowly amoeba pulled off a stunning heist, grabbing genes from an unsuspecting bacterium to replace those it had lost.

• share
• favorite_border

The House Judiciary Committee chair’s nonpartisan conduct of the Watergate hearings ultimately led to President Richard Nixon’s resignation

• share
• favorite_border

ISPOR announced the publication of a report in the September/October issue of Value in Health detailing a new modeling approach that explores the health technology assessment impact of future medical-technology price reductions that are caused by increased adoption and use of these technologies.

• share
• favorite_border

A team at the Rutgers has won a $300,000 contract with the CDC to investigate emergence of antifungal drug resistance by the common fungal pathogen Candida glabrata. Fungal infections are a leading cause of morbidity and mortality among individuals with compromised immune systems. Treatment options are already highly limited.

• share
• favorite_border

With the climate warming and the sea level rising, conditions are ripe for storms deadlier and more devastating than Sandy that put more people at risk. That’s the outlook from David A. Robinson, a Rutgers geography professor who has served as the New Jersey state climatologist for 25 years.

• share
• favorite_border

PPPL physicist Masaaki Yamada helped create the field of laboratory astrophysics.

• share
• favorite_border

It’s the drumbeat you hear every year – time to roll up your sleeve for your annual flu vaccination. But, is it really worth the effort? Does the flu vaccine really work? “In a word: Yes!” says Dr. Claudine De Dan, a Rowan Family Medicine physician and a faculty member at the Rowan University School of Osteopathic Medicine.

• share
• favorite_border

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has published a new report, “Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report,” in the September/October 2016 issue of Value in Health.

• share
• favorite_border

Joseph Labrum, a Science Undergraduate Laboratory Internship student at the U.S. Department of Energy's Princeton Plasma Physics Laboratory, spent his summer internship building components to upgrade an experiment that successfully compared physical objects without learning anything about the objects themselves. Such a “zero-knowledge protocol” system is a promising first step toward a technique that could possibly be used in future disarmament agreements, pending the results of further development, testing, and evaluation. While important questions remain, it might have potential application to verify that nuclear warheads are in fact true warheads without revealing classified information.

• share
• favorite_border

Jeffrey L. Carson, MD, a Rutgers physician who has championed the movement to use less blood in transfusions has been awarded more than $16.1 million by the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) to lead a nation-wide clinical trial aiming to establish evidence that can be used to set transfusion standards for patients who have had a heart attack, to improve their survival rates and reduce the risk of recurrence.

• share
• favorite_border

Article describes multinational contract to study prediction and avoidance of disruptions on South Korea's KSTAR tokamak

• share
• favorite_border

ISPOR held its Initiative on US Value Assessment Frameworks Stakeholder Conference, in Washington, DC, USA on September 23, 2016. The meeting was designed to convene stakeholders across all segments of health care to generate input and help guide the scope of work for the Initiative’s Special Task Force.

• share
• favorite_border

A $250,000 grant from the Breast Cancer Research Foundation awarded to a Rutgers Cancer Institute of New Jersey researcher will help further elucidate the inner workings of the p53 gene. The work will examine a drug compound that restores tumor suppressor function, with an aim of providing a foundation for the development of a new type of anti-cancer drug.

• share
• favorite_border

The Center will provide evidence-based, trauma-informed training and consultation to build the capacity of existing and future providers to treat children with complex trauma and their families across New Jersey